Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)

Completed · Phase 3

Conditions studied: Obstructive Sleep Apnea

In brief

The purpose of this clinical trial is to demonstrate long-term safety and efficacy of the Inspire system. The Inspire Upper Airway Stimulation (UAS) therapy is intended to treat moderate-to-severe obstructive sleep apnea by improving airway patency through stimulation of the hypoglossal nerve. Study objectives include demonstrating that the Inspire system improves key indices of sleep apnea in a pre-specified percentage of patients.

Key facts

Study ID
NCT01161420
Run by
Inspire Medical Systems, Inc.
People needed
929
Starts
2010-07-01
Expected to finish
2017-04-01
Last updated by the study team
2017-08-25

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.